Mannargudi B - Search Results

1

Study of the sequence of events involved in nevirapine-induced skin rash in Brown Norway rats.

Popovic M, Caswell JL, Mannargudi B, Shenton JM, Uetrecht JP. Popovic M, et al. Among authors: mannargudi b. Chem Res Toxicol. 2006 Sep;19(9):1205-14. doi: 10.1021/tx0601152. Chem Res Toxicol. 2006. PMID: 16978025

2

Nevirapine hypersensitivity.

Popovic M, Shenton JM, Chen J, Baban A, Tharmanathan T, Mannargudi B, Abdulla D, Uetrecht JP. Popovic M, et al. Among authors: mannargudi b. Handb Exp Pharmacol. 2010;(196):437-51. doi: 10.1007/978-3-642-00663-0_15. Handb Exp Pharmacol. 2010. PMID: 20020271 Review.

3

A study of the specificity of lymphocytes in nevirapine-induced skin rash.

Chen X, Tharmanathan T, Mannargudi B, Gou H, Uetrecht JP. Chen X, et al. Among authors: mannargudi b. J Pharmacol Exp Ther. 2009 Dec;331(3):836-41. doi: 10.1124/jpet.109.157362. Epub 2009 Sep 4. J Pharmacol Exp Ther. 2009. PMID: 19734442

4

Covalent binding of penicillamine to macrophages: implications for penicillamine-induced autoimmunity.

Li J, Mannargudi B, Uetrecht JP. Li J, et al. Among authors: mannargudi b. Chem Res Toxicol. 2009 Jul;22(7):1277-84. doi: 10.1021/tx900087z. Chem Res Toxicol. 2009. PMID: 19462940

5

Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash.

Chen J, Mannargudi BM, Xu L, Uetrecht J. Chen J, et al. Among authors: mannargudi bm. Chem Res Toxicol. 2008 Sep;21(9):1862-70. doi: 10.1021/tx800177k. Epub 2008 Aug 26. Chem Res Toxicol. 2008. PMID: 18729332

6

Bioactivation of minocycline to reactive intermediates by myeloperoxidase, horseradish peroxidase, and hepatic microsomes: implications for minocycline-induced lupus and hepatitis.

Mannargudi B, McNally D, Reynolds W, Uetrecht J. Mannargudi B, et al. Drug Metab Dispos. 2009 Sep;37(9):1806-18. doi: 10.1124/dmd.109.027292. Epub 2009 Jun 8. Drug Metab Dispos. 2009. PMID: 19505990

7

Engineering d-amino acid containing novel protease inhibitors using catalytic site architecture.

Annedi SC, Biabani F, Poduch E, Mannargudi BM, Majumder K, Wei L, Khayat R, Tong L, Kotra LP. Annedi SC, et al. Among authors: mannargudi bm. Bioorg Med Chem. 2006 Jan 1;14(1):214-36. doi: 10.1016/j.bmc.2005.08.019. Epub 2005 Sep 29. Bioorg Med Chem. 2006. PMID: 16198572

8

A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors.

Rajan A, Carter CA, Kelly RJ, Gutierrez M, Kummar S, Szabo E, Yancey MA, Ji J, Mannargudi B, Woo S, Spencer S, Figg WD, Giaccone G. Rajan A, et al. Among authors: mannargudi b. Clin Cancer Res. 2012 Apr 15;18(8):2344-51. doi: 10.1158/1078-0432.CCR-11-2425. Epub 2012 Feb 27. Clin Cancer Res. 2012. PMID: 22371451 Free PMC article. Clinical Trial.

9

A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas.

Rajan A, Kelly RJ, Trepel JB, Kim YS, Alarcon SV, Kummar S, Gutierrez M, Crandon S, Zein WM, Jain L, Mannargudi B, Figg WD, Houk BE, Shnaidman M, Brega N, Giaccone G. Rajan A, et al. Among authors: mannargudi b. Clin Cancer Res. 2011 Nov 1;17(21):6831-9. doi: 10.1158/1078-0432.CCR-11-0821. Epub 2011 Sep 9. Clin Cancer Res. 2011. PMID: 21908572 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results